Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement

Leuk Lymphoma. 2020 Dec;61(12):2980-2984. doi: 10.1080/10428194.2020.1791849. Epub 2020 Jul 10.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives
  • Central Nervous System
  • Humans
  • Lymphoma, B-Cell, Marginal Zone* / diagnosis
  • Lymphoma, B-Cell, Marginal Zone* / drug therapy
  • Piperidines
  • Pyrazoles / adverse effects
  • Pyrimidines* / adverse effects

Substances

  • Piperidines
  • Pyrazoles
  • Pyrimidines
  • ibrutinib
  • Adenine